Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Pharm Pharm Sci ; 23(1): 75-85, 2020.
Article in English | MEDLINE | ID: covidwho-1727068

ABSTRACT

The presented work summarizes the results of studies underlining the crucial role of estrogen receptor (ER) signaling in both innate and adaptive immune responses as well as in tissue repairing processes during respiratory virus infection. Experimental studies justify that among respiratory virus infected mice, a weaker ER signaling leads to increased morbidity and mortality in both males and females. In animal experiments, estrogen treatment silences the inflammatory reactions and decreases virus titers leading to improved survival rate; it seems to be an ideal prevention and therapy against COVID-19. We should overcome the widespread reluctance to estrogen therapy as we have a unique estrogen formula; conjugated estrogens, or conjugated equine estrogens available under the brand name of Premarin deriving from natural sources. Premarin can exert similar ER upregulative and gene repairing power like endogenous estrogen without any risk for adverse reactions. Premarin is capable of stopping the COVID-19 pandemic.


Subject(s)
Coronavirus Infections/drug therapy , Estrogens/therapeutic use , Pneumonia, Viral/drug therapy , Receptors, Estrogen/physiology , Adaptive Immunity , Age Factors , Animals , Betacoronavirus , COVID-19 , Comorbidity , Coronavirus Infections/mortality , Estrogens, Conjugated (USP)/therapeutic use , Female , Humans , Immunity, Innate , Inflammation/drug therapy , Male , Mice , Pandemics , Pneumonia, Viral/mortality , SARS-CoV-2 , Sex Factors , Signal Transduction , Up-Regulation/drug effects , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL